Cantor Fitzgerald’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.63M Hold
30,036
0.07% 109
2026
Q1
$8.87M Hold
30,036
0.13% 80
2025
Q4
$8.2M Hold
30,036
0.12% 88
2025
Q3
$8.12M Sell
30,036
-4,306
-13% -$1.17M 0.08% 98
2025
Q2
$9.47M Buy
34,342
+4,306
+14% +$1.17M 0.17% 41
2025
Q1
$7.97M Hold
30,036
0.17% 37
2024
Q4
$6.98M Hold
30,036
0.14% 34
2024
Q3
$6.63M Hold
30,036
0.19% 25
2024
Q2
$5.91M Hold
30,036
1.16% 22
2024
Q1
$6.47M Hold
30,036
1.53% 13
2023
Q4
$6.33M Hold
30,036
1.3% 15
2023
Q3
$6.01M Hold
30,036
0.16% 164
2023
Q2
$5.57M Hold
30,036
0.13% 192
2023
Q1
$5.75M Buy
+30,036
New +$5.43M 0.12% 229
2022
Q2
Sell
-30,036
Closed -$7.14M 818
2022
Q1
$7.14M Buy
+30,036
New +$7.05M 0.54% 50

Other funds holding CME

Cantor Fitzgerald's CME Position: Q2 2026 in Review

Cantor Fitzgerald held its CME Group (CME) position steady in Q2 2026 at 30,036 shares worth $6.63M. The position accounts for 0.07% of the portfolio, ranked #109.

Cantor Fitzgerald first reported a position in CME in Q1 2022 and has held it in 15 quarters since. The position peaked at $9.47M in Q2 2025. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Cantor Fitzgerald held 30,036 shares of CME Group worth $6.63M as of Q2 2026.
  • Cantor Fitzgerald left its CME Group share count unchanged in Q2 2026.
  • CME Group made up 0.07% of Cantor Fitzgerald's portfolio in Q2 2026, its #109 holding.
  • Cantor Fitzgerald first reported a position in CME Group in Q1 2022 and has held it in 15 quarters since.
  • Cantor Fitzgerald's CME Group position peaked at $9.47M in Q2 2025.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Cantor Fitzgerald's 13F filing for Q2 2026, filed 14 Aug 2026.